Embryology training for Reproductive Endocrine fellows in the clinical human embryology laboratory by Richard T. Scott et al.
ASSISTED REPRODUCTION TECHNOLOGIES
Embryology training for Reproductive Endocrine fellows
in the clinical human embryology laboratory
Richard T. Scott Jr. & Kathleen H. Hong & Marie D. Werner &
Eric J. Forman & Andrew Ruiz & Michael C. Cheng &
Tian Zhao & Kathleen M. Upham
Received: 2 December 2013 /Accepted: 3 February 2014 /Published online: 21 February 2014
# The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract
Objective To determine if comprehensive embryology train-
ing for clinical Reproductive Endocrinology fellows could be
completed to a level of proficiency equivalent to that of
experienced embryologists.
Method Clinical fellows were integrated into the clinical em-
bryology team and were trained to perform all the various
procedures utilized in clinical embryology. The fellows were
trained to the same standards as the clinical embryology staff
and underwent the same certification and sign off procedures.
To determine if inclusion of clinical fellows on the embryol-
ogy team impacted outcomes, outcomes for individual
oocytes/embryos and the clinical cases where the fellows
perform embryology procedures were compared to the out-
comes of those oocytes/embryos and cases performed by the
full time embryology staff.
Results Clinical procedures performed by the fellows includ-
ed isolation and processing of oocytes following retrieval,
loading catheters for embryo transfer, and vitrification (N=
823 cases). Micromanipulation procedures compared includ-
ed ICSI and assisted hatching (N=650 cases). For each pro-
cedure, the outcomes in those cases performed by the RE
fellows were equivalent to those done by the fully trained
clinical embryology staff.
Conclusions When fellows are trained to perform embryolo-
gy procedures as an integral part of their fellowship curricula,
laboratory efficiencies and clinical outcomes are fully main-
tained. This experience provides valuable insight into the ART
process critical to this subspecialty. It also empowers fellows
to fully participate in research relating to the viability of
gamete and embryos and optimization of the clinical ART
laboratory.
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Introduction
Reproductive Endocrine (RE) training is near unique amongst
medical specialties in that the expected breadth of knowledge
extends far beyond clinical care. Extensive expertise with
developmental biology from the gamete level to full maturity
and then to senescence is expected. Significant knowledge in
the areas of pediatric and medical endocrinology, while out-
side of clinical practice for virtually all Reproductive Endo-
crinologists, is also required [1]. Perhaps most distinctive is
the focus on basic and laboratory science. Fellowship gradu-
ates are expected to have comprehensive knowledge of a
variety of techniques stemming from basic hormonal assays
to newer molecular techniques. This is in spite of the fact that
very few of these individuals will ever return to the laboratory
to actually perform these analyses themselves after complet-
ing fellowship training.
The reason such a broad scientific foundation is required is
clear and unassailable. Reproductive Endocrinology requires
a fundamental understanding of each of these processes to
optimize clinical practice, critically review new medical and
scientific literature, and to empower graduates to become
scientists capable of meaningful investigation. Hands on
Capsule Clinical Reproductive Endocrine fellows may be trained to
perform the full spectrum of embryology procedures including
micromanipulation on actual clinical IVF without compromising
clinical outcomes.
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experience provides valuable insight and understanding about
performing and interpreting research even if that particular
laboratory assay or process is not routinely used in their future
clinical care or research efforts.
Over the last three decades, the development of the assisted
reproductive technologies (ART's) has led to their becoming
the treatment of choice for a substantial portion of infertile
couples. Recent studies have clearly demonstrated that they
are the most successful and cost effective approaches for many
patients requiring clinical care [2, 3]. A significant component
of the ART's are the embryology and andrology laboratories.
In sharp contrast to every other area of Reproductive En-
docrinology, fellowships typically provide little actual embry-
ology training. Reproductive Endocrinology fellowship pro-
grams are required to provide exposure, but this standard may
be met in widely differing ways. Anecdotally, many programs
meet this requirement by having the fellow observe at a
distance within the laboratory while not participating in the
actual processes. Others may not allow the fellows in the
laboratory at all. A few programs provide an opportunity to
interact meaningfully with the laboratory or provide fellows
an optional "training track" which would allow them to par-
ticipate in these laboratories.
The reasons why training in embryology and andrology
laboratories is limited while training extensively in other
laboratory sciences involved in clinical Reproductive Endo-
crinology are varied and are not specifically quantitatable.
One reason might be that having clinical fellows perform
embryology procedures in the actual clinical laboratory would
compromise patient care. In reviewing this premise, there are
no data to support such a supposition. In turn, there are no data
demonstrating that it is safe.
This study seeks to determine if Reproductive Endocrine
fellows may receive comprehensive embryology and androl-
ogy laboratory training in the clinical laboratories, up to and
including the most sophisticated micromanipulation proce-
dures, to a level of proficiency equivalent to that of experi-
enced embryologists.
Materials and methods
Reproductive Endocrinology fellows in the Robert Wood
Johnson fellowship program are required to spend 6 months
in the clinical embryology and andrology laboratories. This is
a relatively new fellowship program. Three fellows have
progressed through their training and all three have completed
their laboratory rotations to date. During that time, they un-
dergo technical training and testing which is identical to that
received by the clinical embryology and andrology staff as
they complete their training and certification. The fellows are
tested to the same standards as clinical embryologists prior to
being allowed to independently perform clinical procedures.
The fellows initially work with discarded biologic material.
They spend an enormous number of hours moving oocytes
which have failed to fertilize, hatching embryos which have
arrested in development, and vitrifying and warming arrested
embryos which are not suitable for either transfer or cryopres-
ervation. The amount of time spent learning and mastering the
technical aspects of each taskwas tracked for each task and for
each individual fellow. Once technical proficiency has been
attained, the fellow is signed off by the supervisor responsible
for that area of the laboratory. They are then placed into the
clinical embryology task rotation and perform actual clinical
cases. An estimate from the senior embryology staff is that
they spent approximately 600 h performing training on the
various techniques before doing actual clinical cases.
Training was systematic and followed a plan sequence but
not a specific time table. Competence at one task was required
before training was begun on another. Just as with any em-
bryologist, the fellows commonly performed clinical proce-
dures for a task for which they had already been signed off
while they trained at a different time of day on another. For
example, they might be the embryologist responsible for
retrievals in the morning while training for hyaluronidase/
stripping prior to ICSI later in the day. The general training
sequence was QA/QC, chart review and preparation, daily
schedule and task list, andrology, retrievals, insemination,
fertilization checks, vitrification including warming, oocyte
stripping prior to ICSI, assisted hatching, ICSI, embryo biop-
sy, and embryo grading. During training, a qualified embry-
ologist supervised the fellows at all times. After being signed
off on a given task, the fellow had the same autonomy as any
of the embryologists certified for that particular task.
It should be noted that prior to training in embryology that
the fellows rotate through the andrology and endocrinology
laboratory and gain proficiency in those laboratories and are
signed off to perform those procedures to rotating through the
embryology laboratory. The fellows do perform andrology
procedures on IVF specimens during their embryology labo-
ratory training.
Gametes and embryos
The subjects in the study are composed of the oocytes and
embryos which are undergoing culture and procedures within
the clinical IVF laboratory. The exposure relates to the em-
bryologist doing the procedure. There are two possible expo-
sures since procedures were performed either by the clinical
Reproductive Endocrinology fellows during their rotation or
by the clinical embryology staff.
Experimental design
The fellows rotate through every workstation within the lab-
oratory. This includes daily QA/QC, chart review and
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preparation, creation of laboratory treatment plans, and dish
preparation. These tasks are essential to good laboratory func-
tion, but the results are difficult to quantitate and were not
included in the study. This study focuses on endpoints which
are more directly evaluable. Specifically, it focuses on the
level of proficiency attained by the fellows for performing
hands on embryology procedures involving actual manipula-
tion of the spermatozoa, oocytes, and embryos. These specific
tasks were divided into three groups.
The first group of procedures relate to identifying, process-
ing, and moving specimens within the laboratory. The initial
comparison focused on performing identification and han-
dling of the oocyte cumulus complexes at the time of retrieval.
The endpoints measured related to the time spent performing
these procedure. Time intervals for isolation of the oocyte
cumulus complexes, cutting and removing excess cumulus,
and the total time for the procedure which includes the first
two steps as well as the time spent to transfer the oocytes into
their initial culture dishes and place them in an incubator.
Effectiveness in loading the catheter at the time of embryo
transfer was measured by assessing pregnancy rates which
ensued from those transfers.
The second group of procedures related to embryo vitrifi-
cation. Two important endpoints were assessed. The first was
the efficiency with which the initial vitrification was accom-
plished. This was evaluated by comparing the proportion of
embryos which survived warming. This step assessed only
which group did the actual vitrification. It did not matter if the
warming phase was done by a fellow or a clinical embryolo-
gist. The second endpoint was the pregnancy outcome follow-
ing transfer of those warmed embryos.
The third group of procedures involved micromanipula-
tion. Two procedures were evaluated- ICSI and assisted hatch-
ing. The outcomes following ICSI were evaluated by compar-
ing the fertilization rate, the eventual proportion of injected
oocytes which formed blastocysts of sufficient quality to be
transferred or be vitrified for future use, and the pregnancy
rate which ensued following fresh transfer of those blasto-
cysts. Skill with assisted hatching was similarly evaluated by
assessing the proportion which progressed to become high
quality blastocysts and the pregnancy rates for those which
were transferred.
Data analysis
All data within the clinical laboratory are tracked real time in
an electronic medical record. Data consistently recorded in the
electronic record include the individual performing the proce-
dure and the results of that procedure. These data, as well as
the clinical outcomes for the overall cycle were extracted from
the electronic medical record as appropriate.
The primary endpoints for each of the procedures were
compared using Student’s t-tests for continuous variables or
contingency table analyses for categorical variables as appro-
priate. An alpha error of 0.05 was considered significant. No
power analysis was done. Study size was determined by
capturing 100 % of the procedures performed by the RE
fellows during their training rotation. Age matched controls
were selected for each case or function based on the subse-
quent five cases performed by the clinical embryology team
providing a 1:5 ratio for this case:control study. The 1:5 ratio
was selected arbitrarily as it provided a large number of
control procedures to enhance the precision of the statistical
result, but was limited to procedures which were typically
performed within 1 day of those done by the clinical RE
fellows. This limit was felt to be prudent to minimize any
impact of non-specific laboratory drift.
There was no evaluation of longitudinal changes in the
performance of the fellows with the various embryology tasks.
This was not practical as the number of procedures being done
was still relatively limited and there was insufficient power to
perform this type of analysis. This retrospective study was
IRB approved.
Results
Three fellows have completed their rotations to date. All
fellows successfully completed their training rotation in every
area within the laboratory and were able to meet the
established performance standards required to be signed-off
to function autonomously. All data regarding the procedures
performed by the fellows and the subsequent outcomes were
recorded and are reported. No procedures or results have been
removed. The list of the procedures which were performed,
the numbers of each performed by the RE fellows, and the
number of controls (always selected on the basis of a 1:5 ratio)
are listed in Table 1.
The first group of procedures to be evaluated related to
isolating and processing oocyte cumulus complexes at the
time of retrieval or loading embryos for transfer to the patient
at completion of the in vitro process. There were no differ-
ences in the time spent to recover and process the oocytes
immediately following retrieval. Specifically, the time spent
looking through the follicular aspirates and isolating the oo-
cyte cumulus complexes (P=0.92), the time spent cutting
excess cumulus away from the oocyte (P=0.72), and the total
time from onset of the retrieval until recovery was complete
with the oocytes put away in an incubator were all equivalent
(P=0.52) (Fig. 1a). Similarly, pregnancy rates were not im-
pacted by whether the catheter was loaded by the fellow or by
a member of the clinical embryology staff (P=0.77) (Fig. 1b).
The second group of procedures dealt with vitrification.
There were no differences in survival for embryos vitrified by
the fellows versus those vitrified by the clinical embryologists
(P=0.22). Those embryos were then transferred. Similarly, the
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ensuing pregnancy rates were equivalent for those embryos
vitrified by the fellows or the clinical embryologists (P=0.85)
(Fig. 2). The number of embryos in those transfers were
equivalent (1.7 versus 1.8) (P=0.92) and the implantation
rates were also equivalent (53 % vs 49 %) (P=0.44) for those
originally vitrified by the RE fellows and embryologists,
respectively.
The final set of evaluations addressed the various micro-
manipulation procedures done in the embryology laboratory.
Following ICSI, there were no differences in fertilization rates
(P=0.89), the proportion of the injected oocytes which be-
came high quality blastocysts (P=0.78), or pregnancy rates
following transfer (P=0.54) (Fig. 3a).
In this program, embryos are hatched on day 3 and placed
into extended culture. Development is observed again on day
5 and if the embryos are of sufficient quality they are either
transferred or considered supernumerary and vitrified for fu-
ture use. The proportion of embryos which blastulated follow-
ing assisted hatching was the same for the RE fellows and the
clinical embryologists (P=0.6) (Fig. 3b).
In summary, the outcomes for procedures performed by the
RE fellows were equivalent to those done by the fully trained
and credentialed clinical embryology staff for all procedures
evaluated.
Discussion
This study demonstrates that it is possible to provide clinical
embryology training to Reproductive Endocrine fellows as an
integral component of their fellowship. The fellows attained a
high level of proficiency with the full spectrum of laboratory
procedures. Most importantly, their training was completed in
the clinical embryology laboratory and they participated in the
care of actual clinical cases without compromising clinical
results.
Incorporation of comprehensive embryology training into
the fellowship program did not require a reduction in any
aspect of the fellows’ clinical training. They spent the full
amount of time prescribed by the American Board of Obstet-
rics and Gynecology on clinical rotations and saw the same
number of patients, performed the same number of surgeries,
and completed the same number of office related procedures
as they would have had they not been rotating through the
embryology laboratory. There is absolutely no compromise in
any aspect of clinical training.
The embryology laboratory in many programs is a sacred
and even mysterious place with extremely limited access. The
thought of conducting RE fellow training in this setting is
daunting. In reality, it is no different than many areas of
training. Thoughtful training algorithms and close supervision
are required. It is wholly analogous to teaching young physi-
cians to do deliveries, perform surgeries, and even do proce-
dures such as oocyte retrievals or embryo transfers. This study
demonstrates that meaningful training may be completed
without compromising clinical results, functionally lifting
the mysterious veil which surrounds these laboratories.
No additional resources should be required when training
Reproductive Endocrine fellows within the embryology and
andrology laboratories. Given that there are no specific grad-
uate programs in human embryology and andrology that
provide hands-on technical training, embryology skills are
Table 1 Types and number of
procedures performed by clinical
RE fellows and their age matched








Oocyte-cumulus complexes recovered and processed at
time of retrieval (cases)
200 1,000
Fertilization check the day following insemination (cases) 173 865
Catheters loaded for embryo transfer (cases) 123 615
Vitrification
Embryos vitrified and subsequently warmed (N) 141 705
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typically attained in a manner which might best be character-
ized as an apprenticeship. As such, almost all programs have
the algorithms and resources in place which allow them to
train and sign-off individuals to perform the various tasks
required in clinical embryology.
The fellows have put their training to use and are continu-
ing to work in the clinical IVF laboratory performing proce-
dures at all levels which relate to a variety of their research
projects. With this ongoing involvement, these fellows will
have a sufficient number of cases to meet the volume of
procedures required to become a High Complexity Laboratory
Director (HCLD) as designated by the American Board of
Bioanalysts. Also with ongoing involvement, they will soon
have sufficient tenure in the laboratory to make them eligible
to sit for the certifying examination to become HCLD’s. To be
clear, there is no requirement that Reproductive
Endocrinologists become qualified to be embryology or an-
drology laboratory directors. Rather, it speaks to the fact that
the training is sufficient to meet the most rigorous regulatory
requirements applied to individuals who work in leadership
positions within laboratories in this field.
The putative benefits of a strong background in embryol-
ogy and andrology are many. A greater understanding of the
inner workings of the laboratory should facilitate better com-
munication with the clinical embryology team. It would also
allow these physicians to take a more active role in QA and
QC in the laboratory throughout their careers. This is partic-
ularly important for many who will become program directors
as they should be involved in all aspects of their ART
program.
It may also facilitate research. Reproductive Endocrine
training allocates a significant amount of time within the
Fig. 1 The ability of
Reproductive Endocrine fellows
to isolate and manipulate gametes
and embryos was assessed.
Isolation and processing of
oocytes at the time of oocyte
retrievals was measured by
looking at the time interval to
identify the oocyte cumulus
complexes, remove the excess
cumulus, and then the total time
for the entire procedure including
washing the recovered oocytes,
transferring them to a culture dish
and then placing them in an
incubator (a). There were no
differences between the RE
fellows and the clinical
embryology team. Pregnancy
rates after loading the catheter at
the time of embryo transfer were
also equivalent for the RE fellows
and clinical embryologists (b)
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fellowship for research. In general, this protected time allows
fellows with laboratory based projects to go into the labora-
tory and gain actual proficiency with both the technical and
theoretical aspects of sample preparation as well as perfor-
mance of the assays used to evaluate them. To attain an
equivalent level of involvement for projects involving gam-
etes or embryos, fellows must participate in the care of the
embryos (intervention studies) or at least collection of biologic
specimens (studies of discarded material).
The significant technical proficiency in handling and pro-
cessing spermatozoa, oocytes, and embryos as well as with
embryo vitrification and the performance of sophisticated
micromanipulation procedures empower fellows to fully
participate in any projects involving gametes or embryos.
With rapid development of the “Omics” technologies, a
strengthened focus has emerged on evaluating gametes, em-
bryos, cumulus, and spent culture media [4–7]. The attained
technical skills have already facilitated translational research.
The fellows are providing clinical and embryology care in five
randomized clinical trials at the current time.
Not having an individual fellow attain these skills does not
preclude them from meaningful participation in research re-
lated to gametes or embryos. Rather, development of the core
skills sets described in this study might empower them to
participate more fully in those types of projects. Hopefully
having this group of young physicians develop expertise
Fig. 2 When evaluating embryos
which were vitrified by either the
RE fellows or the clinical
embryology team, there were no
differences in the survival rates






by comparing outcomes for those
procedures performed by the RE
fellows relative to the clinical
embryology staff. For ICSI, there
were no differences in fertilization
rates, the proportion of embryos
which formed high quality
embryos, or the pregnancy rates
which ensued following transfer.
Similarly, outcomes following
assisted hatching were equivalent
for both the fellows and the
embryologists
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across the full breadth of reproductive biology, laboratory
science, and clinical Reproductive Endocrinology should be
empowering if their research focus deals with any aspect of
clinical or basic science gamete or embryo biology.
Should there be a role for embryology training in all
fellowships? It is not a technical requirement at this time and
there are a great number of outstanding Reproductive Endo-
crinologists who did not have this type of training during their
fellowship. In spite of that, it is the opinion of the authors that
participating in the laboratory will make it easier for Repro-
ductive Endocrinologists to become outstanding investigators
in these areas.
At the current time, the data from this study demonstrate
that it is possible to safely provide embryology and andrology
training without adversely impacting clinical outcomes for the
patients receiving care within the division. This should em-
power training in clinical embryology – especially for those
fellows pursuing ART related research projects or those who
will choose to focus on ART during their career.
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